INFICON Explorer Portable Gas Chromatograph User Manual
Page 359
Explorer Operator Manual
357
(b) the maximum quantity of the prescribed substance likely to be
required at any one time for the purpose set out in the
application;
(c) a description of the premises in which the prescribed substance
is to be located and of any equipment in connection with which
it is to be used;
(d) a description of the measures to be taken to prevent theft, or loss
or any unauthorized use of the prescribed substance;
(e) a description of the measures to be taken, including any plan in
case of accident, to prevent the receipt by any person of a dose
of ionizing radiation [or an exposure to radon daughters] in
excess of any dose specified in respect of such person in
Schedule II;
(f) a description of the method of diagnosing of the radioactive
prescribed substance;
(g) a description of the qualifications, training, and experience of
any person who is to use the prescribed substance; and
(h) any other information necessary to evaluate the application.
(3) [A license issued by the Board or a designated officer pursuant to
subsection (1) may contain such conditions as the Board or the
designated officer deems necessary in the interests of health, safety
and security and, without limiting the generality of the foregoing,
may include conditions respecting]
(a) the measures to be taken to prevent the receipt by any person of
a dose of ionizing radiation [or an exposure to radon daughters]
in excess of any dose specified in respect of such person in
Schedule II;
(b) the monitoring devices and other methods for measuring the
dose of ionizing radiation [or exposure to radon daughters]
received by any person;